Document Detail


Combination therapy of benign prostate syndrome/lower urinary tract symptoms.
MedLine Citation:
PMID:  23340696     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The pathophysiology of lower urinary tract symptoms (LUTS) is multifactorial. The fact that none of the available drugs impacts on more than one of these pathomechanisms, provides the rationale for combined medical treatment strategies. The combination of α-blocker and a 5-reductase inhibitor is recommended by all major benign prostate hyperplasia (BPH/LUTS) guidelines as a first line approach for men with moderate to severe LUTS and a higher risk for disease progression. The efficacy of this approach has been proven in prospective randomized trials for up to 4 years. The combination of α-blocker and antimuscarinics has been tested in several randomized trials as a primary approach or as add on therapy but the maximum study duration was only 3 months. The add on approach is suitable in particular for men with persisting storage symptoms under α-blockade. The risk for acute retention in appropriately selected men is low. The scientific basis for all other combinations is not solid enough to recommend the use outside clinical trials.
Authors:
S Madersbacher
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-24
Journal Detail:
Title:  Der Urologe. Ausg. A     Volume:  -     ISSN:  1433-0563     ISO Abbreviation:  Urologe A     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1304110     Medline TA:  Urologe A     Country:  -    
Other Details:
Languages:  GER     Pagination:  -     Citation Subset:  -    
Affiliation:
Abteilung für Urologie, Donauspital, Langobardenstraße 122, A-1220, Wien, Österreich, stephan.madersbacher@wienkav.at.
Vernacular Title:
Kombinationstherapie bei benignem Prostatasyndrom/unterer Harntraktsymptomatik.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long-Term Survival After Gastrectomy for Cancer in Randomized, Controlled Oncological Trials: Compar...
Next Document:  Preliminary experience on treatment of infantile hemangioma with low-dose propranolol in China.